5 research outputs found

    투명 페로브스카이트 반도체 알칼리토 주석 산화물의 p 형 도핑과 그 pn 접합 연구

    Get PDF
    학위논문 (박사)-- 서울대학교 대학원 : 물리·천문학부(물리학전공), 2014. 2. 차국린.Abstract Transparent oxide semiconductors (TOSs) are widely used as transparent electrodes because they are optically transparent in the visible light and UV regions and their electrical conductivity can be manipulated. However, applications of TOSs are limited to transparent electrodes and panel displays because of a lack of p-type conducting transparent oxide materials. The discovering and developing Cu-based p-type TOSs has allowed the fabrication of fundamental semiconductor devices such as pn junctions and field effect transistorshowever, there are few reports of TOS materials that can be injected with dopants to from both p- and n-type materials. Recently, it was reported that La-doped BaSnO3 (BLSO) has high oxygen stability and good electrical conductivity. However, even though BSO thin films exhibit a high epitaxiality, the films contains many grain boundaries and dislocations that act as charge traps and scattering centers. We are attempting to find a substrate more suitable than SrTiO3 (STO) for improving the electrical properties of BLSO thin filmshowever, BLSO thin films on alternative substrates show a poorer mobility than those on STO. In addition, the low doped BLSO thin film acts like a p-type semiconductor due to the effects of threading dislocations even though the dopant is an n-type carrier. Because the d-orbital does not participate in the bonding between Sn and O in BaSnO3 (BSO), this bond can be stronger than that in other perovskite materials, and allows for the possible doping with a p-type carrier. We have been successfully in doping BSO with K using pulsed laser deposition. Although K-doped BSO exhibits a rather high resistivity at room temperature, its conductivity increased dramatically at higher temperatures. The activation energy of the K-dopant was estimated to be about 0.5 eV. Furthermore, the conductivity decreased when a small amount of oxygen was removed from the film, consistent with the behavior of p-type doped oxides. The results of doping BSO with other elements such as Ga and Cu are presented. We have fabricated pn junctions using K-doped BSO (BKSO) and BLSO as the p- and n-type semiconductors, respectively. I-V characteristics of these devices showed the typical rectifying behavior of pn junctions in room temperature. In addition, I-V characteristics of these devices exhibit an ideal diode behavior with the ideality factor between 1 and 2 in high temperature, implying high integrity of the BSO materials. Moreover, the junction properties were found to be very stable after repeated high-bias, high-temperature thermal cycling. Our demonstration of pn junctions based on a single perovskite BSO further enhances the potential of a transparent perovskite semiconductor BSO system, whose high mobility and stability have previously been shown. We investigated SrSnO3 (SSO), which has a 4 eV direct band gap. SSO thin films were deposited on KTaO3 (KTO) to minimize the lattice mismatch with SSO. Images obtained with TEM and AFM showed that the SSO thin films on KTO exhibit almost no threading dislocations. In measuring the electrical properties of the SSO thin films with various dopants such as Sb, La and Ru, we found that the mobility was generally lower than that of BLSO thin films due to tilting of the SnO6 octahedral. Ru-doped SSO showed p-type behavior even at room temperature. We fabricated a pn junction using Sb-doped SSO and Ru-doped as the n- and p-type semiconductors, respectively. We found that the current of the SSO based pn junction was higher than that based on BSO systemthere were several problems with the pn junction, such as large leakage current and large parasitic resistance. If we combine the BSO and SSO system, however, it will be possible to fabricate LED devices because of the direct band gap, low leakage current pn junction and low resistivity conduction.Contents Abstract…………………………………………………………………………i Contents………………………………………………………………………..iv List of Tables…………………….………………………………...………….vii List of Figures………...………………………………………………...……viii 1. Introduction……………………………………………………………..1 1.1 P-doping on oxides and their pn junctions……………………....1 1.2 BaSnO3: transparent perovskite semiconductor……..………….6 1.3 Reference………………………………………………………..8 2. Properties of n-type BSO thin films ………………………..………..12 2.1 Properties of BLSO thin films at various substrates……...……14 2.1.1 BLSO thin film deposition………………………………….14 2.1.2 r-cut sapphire……………………………………………….15 2.1.3 MgAl2O4……………………………………………………16 2.1.4 MgO……...…………………………………………………18 2.2 High temperature experiment of BLSO thin film…………...…20 2.3 Reference………………………………………………………22 3. Properties of p-type BSO thin films …………………………………24 3.1 K-doped BSO (BKSO) thin films…………...…………………24 3.1.1 BKSO thin film deposition………………………...………...24 3.1.2 Electron spectroscopy for chemical analysis………...………25 3.1.3 Structural and surface properties of BKSO thin films…….…27 3.1.4 High temperature measurement of BKSO thin film……...….30 3.1.5 Summary………………………………………………….….31 3.2 Other p-type doping BSO thin film……………………………33 3.2.1 Ga-doped BSO (BSGO) thin film….………………………...33 3.2.2 Cu-doped BSO (BSCO) thin film…………………..………..35 3.3 Reference………………………………………………………37 4. pn junction fabricated with BLSO and BKSO……………………..39 4.1 Theory…………………………..…………...…………………39 4.1.1 Electrostatic analysis of pn junction..………………………...39 4.1.2 The ideal I-V characteristics……………………………….....43 4.1.3 The asymmetry pn junction………………………………......44 4.2 Fabrication of pn junction…...…………………………………45 4.3 I-V characteristics of pn junction………………………………47 4.3.1 The confirmation of ohmic contact ………………..………...47 4.3.2 I-V characteristics of pn junctions……………………………50 4.3.3 High-temperature stability of pn junction……………………57 4.4 Analysis of pn junction…………………..……………………58 4.5 Reference……………………………………………………...63 5. The properties of SrSnO3 thin films & their pn junction…………..65 5.1 Structural properties of SrSnO3 thin film…………………….65 5.2 Properties of SSO thin films …………………...………….…68 5.2.1 SSO thin film deposition…………………………………..68 5.2.2 Structure and dislocations in SSO thin film………………..71 5.3 Structural properties of SrSnO3 thin film…………………….75 5.3.1 Sb-doped SSO (SSSO) thin films……...……..……………75 5.3.2 La-doped SSO (SLSO) thin films……...……..……………77 5.3.3 Ru-doped SSO (SSRO) thin films……...……..……...……78 5.4 pn junctions fabricated with SSSO and SSRO…….………….80 5.4.1 Fabrication of pn junction ……...…...…………..………...80 5.4.2 I-V characteristics of pn junction…………………………81 5.5 Reference……………………………...………………………83 6. Summary…………………………………………………...…………..86 Abstract (In Korean)……………………………...………………………..88Docto

    Metastasis of Renal Cell Carcinoma to the Mandible: A Case Report

    No full text
    Tumors metastasizing to the oral cavity are uncommon and comprise only approximately 1% of the neoplasms in the oral cavity. A 76-year-old man was referred from a local dental clinic with a 3-month history of swelling and pain in the right side of the mandible. He reported a history of clear-cell renal cell carcinoma in the left kidney treated by nephrectomy 18 years ago. Additionally, he had undergone right-upper lobectomy of the lungs for clear-cell renal cell carcinoma metastasis 13 years previously. Orthopantomogram showed multilocular radiolucent lesion in the right posterior region of the mandible. Computed tomography revealed a 3.5×4.0-cm sized lobulated contour mass with bone destruction in the right mandibular angle. Moreover, he underwent segmental mandibulectomy with excision of the lesion under general anesthesia, followed by reconstruction using a reconstruction plate. The postoperative histological diagnosis was clear-cell renal cell carcinoma. The kidneys did not show any evidence of recurrence

    The Study of the Risk Factors and Bone Mineral Density Related to Medication-related Osteonecrosis of the Jaw

    No full text
    To examine risk factors of MRONJ and compare whether there is a difference in BMD value depending on the duration of administration, method of administration, and occurrence of MRONJ. We selected 53 patients who were diagnosed with MRONJ at the Ulsan University Hospital and underwent surgery between January 2011 and May 2021. The risk factors are age, sex, systemic disease, location, administration methods, type of drug, duration, local factors and stage. 19 patients, especially those who were diagnosed with MRONJ and underwent BMD, were compared with BMD in femur and lumbar areas according to duration, administration methods. There were many women in all age groups, with 18 in their 70s. There were about twice as many mandibles as the maxilla. It was significantly higher when the IV BPs was administered in cancer patients, and significantly higher when the oral BPs was administered in osteoporosis patients. There was a significant difference between each period in patients taking oral BPs, and the incidence of MRONJ was high when taking them for more than 4 years. There were 35 patients who developed into MRONJ after dentoalveolar surgery. There were significant differences in femur and lumbar BMD, T-scores by administration method, with lumbar BMD, T-scores being significantly higher in the IV BP group compared to the oral BP group

    The study of the risk factors related to MRONJ(Medication-related osteonecrosis of the jaw)in osteoporosis patients.

    No full text
    Recently, many side effects such as bone necrosis have been reported during dental treatment for patients with osteoporosis as an underlying disease. In particular, osteoporosis is on the rise every year in menopause women and elderly patients, and occurs in connection with bisphosphonate medication. Such medication-related osteonecrosis of the jaw is often caused by surgical dental treatment, and it is difficult to cure when it occurs, so prevention is important. Surgical treatment may be re quired in the oral Preparation process for extraction or prosthetic repair due to periodontal disease, and for the successful treat ment of osteoporosis patients, dentists should fully understand and pay attention to the treatment of osteoporosis patients
    corecore